Akita Biosciences Announces Grant from the Flu Lab to Study Profi Nasal Spray in U.S. Healthcare Workers
Summary
Profi is drug-free and built on a novel platform technology developed in the labs of Dr. Jeff Karp and Dr. Nitin Joshi at Harvard Medical School and Brigham and Womens Hospital. The platform is designed to form a uniform, gel-like barrier in the nasal passages that blocks and helps clear airborne particles.California-based Flu Lab is an organization founded to advance innovative approaches for the prevention and treatment of influenza. The funding will support a prospective pilot study of Profi Nasal Spray in collaboration with the nations largest public healthcare system, NYC Health + Hospitals. Existing measures like masking and vaccines help, but theres a clear need for complementary tools that fit seamlessly into daily practice," said Alex Revelos, co-founder and CEO of Akita Biosciences. While traditional supplements focus on general wellness, our approach targets the nasal passageswhere airborne germs, allergens, and irritants often first enter the body.